Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Background: A RP high performance LC scheme was settled for assessment of Rifapentine in matter then pharmaceutical prescription form that is modest, specific, truthful and delicate to be castoff in repetitive daily analysis